Chris P. Holstege, MD

Chris P. Holstege, MD

Christopher P. Holstege, MD

Professor of Emergency Medicine and Pediatrics
Director, Division of Medical Toxicology
Division of Medical Toxicology
P.O. Box 800699
Charlottesville, VA 22908-0699
Phone: (434) 924-5185
Fax: (434) 971-8657                                                            


  • BS, Chemistry, Calvin College (1988)
  • MD, Wayne State University School of Medicine (1993)
  • Residency, Emergency Medicine, Butterworth Hospital (1996)
  • Fellowship, Medical Toxicology, Indiana University (1998)


Clinical and Research Interests:

  • Clinical Toxicology
  • Chemical agents utilized in terrorism/murder
  • Electrocardiographic changes in the poisoned patient
  • Calcium channel blocker induced hyperglycemia


Personal Interests:

  • Wilderness medicine (orienteering without street signs)
  • White water rafting (near drowning resuscitation in the wilds of West Virginia)
  • Great Lakes sailing (cold water response and survival)


Most Recent Publications:

  • Saathoff G, DeFrancisco G, Benedek D, Everett A, Holstege C, Johnson S, Lambertia S, Schouten R, White J. Report of the Expert Behavioral Analysis Panel – Amerithrax Case.  Research Strategies Network 2011.
  • Holstege CP, Neer T, Saathoff G, Furbee RB.  Criminal Poisoning. Jones and Bartlett Publishers, Inc. Sudbury, Massachusetts.  April, 2010.
  • Bechtel LK, Lawrence D, Holstege CP. Ingestion of False Hellebore Plants Can Cross-react with a Digoxin Clinical Chemistry Assay. Clin Toxicol 2010;48(5):435-442.
  • Louters LL, Stehouwer N, Rekman J, Tidball A, Cok A, Holstege CP. Verapamil inhibits the glucose transporter GLUT1.  J Med Toxicol 2010;6(2):100-5.
  • Forrester JD, Holstege CP. Injury and Illness Encountered in Shenandoah National Park. Wilderness Environ Med 2009;20(4):318-326.
  • Bechtel LK, Haverstick DM, Holstege CP. Verapamil Toxicity Dysregulates the Phosphatidylinositol 3-Kinase Pathway.  Acad Emerg Med 2008;15(4):368-374